HAI Pathogens and Antimicrobial Resistance Report Data Tables, 2018-2021

Pediatric Data Tables

Print
PAGE 11 of 11

‹View Table of Contents

Related Pages

Table P10. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1 for High-volume Surgical Categories2, Pediatrics, 2018-2021

Table P10. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1 for High-volume Surgical Categories, Pediatrics, 2018-2021
    All Surgery Types Abdominal Orthopedic Neurosurgical Cardiac
  Pathogen, Antimicrobial Phenotype # Reported % Tested %R # Reported % Tested %R # Reported % Tested %R # Reported % Tested %R # Reported % Tested %R
Urgent

Threats

 Acinetobacter spp. 20 2 3 11 2
Carbapenem-NS . . . . . . . . . .
Select Enterobacterales3 1,386 1,014 223 105 32
Carbapenem-resistant (CRE) 75.6 1.0 75.5 1.2 71.7 0.6 82.9 0.0 78.1 0.0
Serious

Threats

 Select Enterobacterales4 1,079 834 152 69 15
Extended-spectrum cephalosporin-NS 86.2 17.0 85.3 17.4 85.5 17.7 95.7 7.6 . .
Enterobacter spp. 286 169 64 33 17
Cefepime-NS 83.9 9.2 84.0 9.9 82.8 7.5 78.8 7.7 . .
Enterococcus faecalis 306 235 21 21 25
Vancomycin-resistant (VRE) 86.9 0.0 88.1 0.0 . . . . 80.0 0.0
Enterococcus faecium 62 54 7 1 0
Vancomycin-resistant (VRE) 90.3 12.5 90.7 10.2 . . . . . .
Pseudomonas aeruginosa 449 253 100 64 26
Multidrug-resistant (MDR) 95.5 1.4 98.4 1.6 96.0 2.1 87.5 0.0 88.5 0.0
Staphylococcus aureus 891 220 273 202 171
Meth/ox/cefox – resistant (MRSA) 86.6 25.4 90.5 32.7 86.1 19.6 83.7 29.0 84.8 17.2

 

Note: Percent resistance is not calculated when the number of tested isolates is < 20. Refer to Technical Resources for more information about phenotype definitions, acronyms, and terms used in this table.

Footnotes:

  1. As classified by CDC’s 2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance [PDF – 10.7 MB]
  2. The top 4 surgical categories by pathogen volume are shown in this table. “All surgery types” consists of all NHSN procedures combined, and is not limited to the 4 categories shown in the table. Refer to CDC’s Antibiotic Resistance & Patient Safety Portal for antimicrobial resistance data for each NHSN procedure code.
  3. Consists of E. coli, Klebsiella oxytoca, Klebsiella pneumoniae, Klebsiella aerogenes, and Enterobacter spp.
  4. Consists of E. coli, Klebsiella oxytoca, and Klebsiella pneumoniae.

HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Pediatric HAIs

  1. HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Pediatric HAIs
  2. Table P1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
  3. Table P2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
  4. Table P3: The Top 15 HAI Pathogens Reported to NHSN
  5. Table P4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
  6. Table P5. The Top 15 CAUTI Pathogens Reported to NHSN
  7. Table P6. Frequency of SSI Pathogens, by Surgical Category and SSI Type
  8. Table P7. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
  9. Table P8. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  10. Table P9. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats
  11. ›Table P10. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for High-volume Surgical Categories